My Size (MYSZ) EBITDA (2014 - 2026)

My Size (MYSZ) has reported EBITDA for 13 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 193.86% year-over-year to -$1.7 million; the trailing twelve-month figure through Jun 2026 stood at -$6.4 million (down 75.78% YoY), and the FY2025 full-year result was -$5.7 million, down 45.54% from the prior year.
• EBITDA rose to -$1.7 million in Q2 2026 per MYSZ's latest filing, from -$2.7 million in the prior quarter.
• Across five years, EBITDA topped out at -$586000.0 in Q2 2025 and bottomed at -$2.7 million in Q4 2025.
• Historically, EBITDA has averaged -$1.5 million across 5 years, with a median of -$1.6 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBITDA jumped 61.7% in 2022, then sank 296.81% in 2025.
• Over 5 years, EBITDA stood at -$2.4 million in 2022, then soared by 33.14% to -$1.6 million in 2023, then soared by 56.6% to -$690000.0 in 2024, then tumbled by 296.81% to -$2.7 million in 2025, then soared by 37.11% to -$1.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$1.7 million, -$2.7 million, and -$1.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.